SCHEMBL404447

SCHEMBL404447

NC(CCC(=O)O)C(=O)OC(C(=O)O)C(=O)O.[NaH].[NaH].[NaH].[NaH]

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRM8 O00222 1/20 0.57
GRM6 O15303 1/20 0.57
GRIN2D O15399 1/20 0.57
GRIN3B O60391 1/20 0.57
GSR P00390 1/20 0.57
CYP1A2 P05177 1/20 0.57
GRIK1 P39086 1/20 0.57
GRM5 P41594 1/20 0.57
GRIA1 P42261 1/20 0.57
GRIA2 P42262 1/20 0.57
GRIA3 P42263 1/20 0.57
SLC1A3 P43003 1/20 0.57
SLC1A2 P43004 1/20 0.57
SLC1A1 P43005 1/20 0.57
GRIA4 P48058 1/20 0.57
GRIN1 Q05586 1/20 0.57
GRIN2A Q12879 1/20 0.57
GRIK2 Q13002 1/20 0.57
GRIK3 Q13003 1/20 0.57
GRIN2B Q13224 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16735412 0.98 GRM8 (0.55) GRM8GRM6GRIN2DGRIN3BGSR
SCHEMBL28989733 0.98 CYP1A2 (0.59) GRM8GRM6GRIN2DGRIN3BGSR
SCHEMBL4904816 0.98 CYP1A2 (0.59) GRM8GRM6GRIN2DGRIN3BGSR
Ammonia Solution, Strong SCHEMBL29126348 0.96 GRM8 (0.57) GRM8GRM6GRIN2DGRIN3BGSR
Ammonia Solution, Strong SCHEMBL16735416 0.94 GRM8 (0.55) GRM8GRM6GRIN2DGRIN3BGSR
SCHEMBL28138215 0.87 SLC1A1 (0.41) GRM8GRM6GRIN2DGRIN3BGSR
SCHEMBL4904802 0.85 SLC1A1 (0.42) GRM8GRM6GRIN2DGRIN3BGSR
SCHEMBL710039 0.85 SLC1A1 (0.42) GRM8GRM6GRIN2DGRIN3BGSR
SCHEMBL404450 0.81 CA1 (0.39) GRM8GRM6GRIN2DGRIN3BGSR
SCHEMBL21490308 0.81 CA1 (0.39) GRM8GRM6GRIN2DGRIN3BGSR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240065962-A1 COSMETIC PREPARATION SHISEIDO COMPANY, LTD. (JP) 2024-02-29 US claimed
EP-4292582-A1 COSMETIC PREPARATION Shiseido Company, Ltd. (JP) 2023-12-20 EP claimed
WO-2022082915-A1 HIGH-CONCENTRATION DETERGENT AND PREPARATION METHOD THEREFOR 沈阳脱普生活用品服务有限公司上海分公司 2022-04-28 WO claimed
WO-2012055855-A1 CONCENTRATED PREPARATIONS OF LAE AND THEIR USE LABORATORIOS MIRET, S.A. (ES) 2012-05-03 WO claimed
US-12157869-B2 Methods and compositions for reducing persistent odor in clothing and mitigating biofilms on various materials LINDSAY JEFFREY DEAN (US) 2024-12-03 US disclosed
US-20240065962-A1 COSMETIC PREPARATION SHISEIDO COMPANY, LTD. (JP) 2024-02-29 US disclosed
EP-4292582-A1 COSMETIC PREPARATION Shiseido Company, Ltd. (JP) 2023-12-20 EP disclosed
EP-4038174-B1 MACHINE DISHWASHER CAPSULE WITH THREE COMPARTMENTS UNILEVER IP HOLDINGS B V (NL) 2023-07-12 EP disclosed
US-20220325210-A1 MACHINE DISHWASHER CAPSULE WITH THREE COMPARTMENTS CONOPCO INC., D/B/A UNILEVER (US) 2022-10-13 US disclosed
WO-2022082915-A1 HIGH-CONCENTRATION DETERGENT AND PREPARATION METHOD THEREFOR 沈阳脱普生活用品服务有限公司上海分公司 2022-04-28 WO disclosed
EP-3124562-B1 INK JET TEXTILE PRINTING PENETRANT AND INK JET RECORDING APPARATUS SEIKO EPSON CORP (JP) 2021-03-03 EP disclosed
US-20210032570-A1 METHODS AND COMPOSITIONS FOR REDUCING PERSISTENT ODOR IN CLOTHING AND MITIGATING BIOFILMS ON VARIOUS MATERIALS Planet Lindsay, LLC (US) 2021-02-04 US disclosed
US-20170029636-A1 INK JET TEXTILE PRINTING PENETRANT AND INK JET RECORDING APPARATUS SEIKO EPSON CORPORATION (JP) 2017-02-02 US disclosed
EP-3124562-A2 INK JET TEXTILE PRINTING PENETRANT AND INK JET RECORDING APPARATUS Seiko Epson Corporation (JP) 2017-02-01 EP disclosed
EP-3122858-A1 DISHWASHING COMPOSITION CONTAINING CELLULYTIC ENZYMES AND USE THEREOF Novozymes A/S (DK) 2017-02-01 EP disclosed
EP-2424526-B1 A PHARMACEUTICAL, DERMATOLOGICAL, NUTRITIONAL OR COSMETIC COMPOSITION FOR COMBATING THE IMMUNOSUPPRESSIVE ACTION OF AGGRESSIVE AGENTS ON THE SKIN GIULIANI SPA (IT) 2016-07-13 EP disclosed
WO-2015144782-A1 DISHWASHING COMPOSITION CONTAINING CELLULYTIC ENZYMES AND USE THEREOF NOVOZYMES A/S (DK) 2015-10-01 WO disclosed
US-9138394-B2 Pharmaceutical, dermatological, nutritional or cosmetic composition for combating the immunosuppresive action of aggressive agents on the skin GIULIANI S.P.A. (IT) 2015-09-22 US disclosed
WO-2012055855-A1 CONCENTRATED PREPARATIONS OF LAE AND THEIR USE LABORATORIOS MIRET, S.A. (ES) 2012-05-03 WO disclosed
US-20120020902-A1 PHARMACEUTICAL, DERMATOLOGICAL, NUTRITIONAL OR COSMETIC COMPOSITION FOR COMBATING THE IMMUNOSUPPRESSIVE ACTION OF AGGRESSIVE AGENTS ON THE SKIN GIULIANI S.P.A. (IT) 2012-01-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120020902-A1 PHARMACEUTICAL, DERMATOLOGICAL, NUTRITIONAL OR COSMETIC COMPOSITION FOR COMBATING THE IMMUNOSUPPRESSIVE ACTION OF AGGRESSIVE AGENTS ON THE SKIN TP53, DSG1, FOXM1 GRM8 4403/4885GRM6 3472/4885GRIN2D 3437/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.